Pubblicazioni sottomesse alla valutazione del Ministero della Salute – 2019

Linea di ricerca 1

CARATTERIZZAZIONE BIO-GENOMICA DEI TUMORI SOLIDI: NUOVE PROSPETTIVE PER LA DIAGNOSTICA MOLECOLARE, L’IMAGING E LA PERSONALIZZAZIONE DEI TRATTAMENTI Chirurgia generale:

- Pucciarelli S, Del Bianco P, Pace U, Bianco F, Restivo A, Maretto I, Selvaggi F, Zorcolo L, De Franciscis S, Asteria C, Urso EDL, Cuicchi D, Pellino G, Morpurgo E, La Torre G, Jovine E, Belluco C, La Torre F, Amato A, Chiappa A, Infantino A, Barina A, Spolverato G, Rega D, Kilmartin D, De Salvo GL, Delrio P. Multicentre randomized clinical trial of colonic J pouch or straight stapled colorectal reconstruction after low anterior resection for rectal cancer. Br J Surg. 106:1147-1155, 2019

- Neola B, Puppio B, Marino G, La Torre G. Is it always necessary to perform an axillary lymphnode dissection on patients undergoing neoadjuvant therapy? Outcomes of a retrospective study. Ann Ital Chir. 90:292-296, 2019

Epidemiologia registro tumori:

- Buzzoni C, Crocetti E, Guzzinati S, Dal Maso L, Francisci S, (Galasso R. collaborator in appendice);

AIRTUM Working Group. Cancer incidence and mortality trends from 2003 to 2014 in Italy. Tumori.

105:121-137, 2019 (Pubblicazione non sottomessa alla valutazione del Ministero della Salute)

- Zorzi M, Dal Maso L, Francisci S, Buzzoni C, Rugge M, Guzzinati S, (Galasso R. collaborator in appendice);

AIRTUM Working Group. Trends of colorectal cancer incidence and mortality rates from 2003 to 2014 in Italy. Tumori. 105: 417-426, 2019 (Pubblicazione non sottomessa alla valutazione del Ministero della Salute)

- Zorzi M, Zappa M, (Galasso R. collaborator in appendice); AIRTUM Working Group. Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates. Gut.

69:311-316, 2020 (Pubblicazione non sottomessa alla valutazione del Ministero della Salute)

- Zona A, Iavarone I, Buzzoni C, Conti S, Santoro M, Fazzo L, Pasetto R, Pirastu R, Bruno C, Ancona C, Bianchi F, Forastiere F, Manno V, Minelli G, Minerba A, Minichilli F, Stoppa G, Pierini A, Ricci P, Scondotto S, Bisceglia L, Cernigliaro A, Ranzi A, Comba P, (Galasso R. collaborator in appendice); Gruppo di lavoro AIRTUM-SENTIERI. [SENTIERI: Epidemiological Study of Residents in National Priority Contaminated Sites. Fifth Report]. Epidemiol Prev. 43:1-208, 2019

(Pubblicazione non sottomessa alla valutazione del Ministero della Salute)

- Zorzi M, Cavestro GM, Guzzinati S, Dal Maso L, Rugge M, (Galasso R. collaborator in appendice);

AIRTUM Working Group. Decline in the incidence of colorectal cancer and the associated mortality in young Italian adults. Gut.16, 2019 (Pubblicazione non sottomessa alla valutazione del Ministero della Salute)

Oncologia ginecologica:

- Mandato VD, Torricelli F, Palomba S, Uccella S, Pirillo D, Ciarlini G, De Iaco P, Lucia E, Giorda G, Ditto A, Ghezzi F, Sanseverino F, Franchi M, Bifulco G, Mastrofilippo V, Abrate M, Aguzzoli L, La Sala GB. Uterine Papillary Serous Carcinoma Arising in a Polyp: A Multicenter Retrospective Analysis on 75 Patients. Am J Clin Oncol. 42:472-480, 2019

Laboratori di ricerca:

- Sisinni L, Pietrafesa M, Lepore S, Maddalena F, Condelli V, Esposito F, Landriscina M. Endoplasmic Reticulum Stress and Unfolded Protein Response in Breast Cancer: The Balance between Apoptosis and Autophagy and Its Role in Drug Resistance. Int J Mol Sci. 20:857, 2019

- Ruggieri V, Russi S, Zoppoli P, La Rocca F, Angrisano T, Falco G, Calice G, Laurino S. The Role of MicroRNAs in the Regulation of Gastric Cancer Stem Cells: A Meta-Analysis of the Current Status. J Clin Med. 8:639, 2019

- Zoppoli P, Calice G, Laurino S, Ruggieri V, La Rocca F, La Torre G, Ciuffi M, Amendola E, De Vita F, Petrillo A, Napolitano G, Falco G, Russi S. TRPV2 Calcium Channel Gene Expression and Outcomes in Gastric Cancer Patients: A Clinically Relevant Association. J Clin Med. 8:662, 2019

- Tataranni T, Agriesti F, Pacelli C, Ruggieri V, Laurenzana I, Mazzoccoli C, Sala GD, Panebianco C, Pazienza V, Capitanio N, Piccoli C. Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines. Cells. 8, 478, 2019

- Condelli V, Crispo F, Pietrafesa M, Lettini G, Matassa DS, Esposito F, Landriscina M, Maddalena F.

HSP90 Molecular Chaperones, Metabolic Rewiring, and Epigenetics: Impact on Tumor Progression and Perspective for Anticancer Therapy. Cells. 8:532, 2019

- Zadorozhna M, Tataranni T, Mangieri D. Piperine: role in prevention and Progression of cancer. Mol Biol Rep. 46:5617-5629, 2019

- Crispo F, Condelli V, Lepore S, Notarangelo T, Sgambato A, Esposito F, Maddalena F, Landriscina M.

Metabolic Dysregulations and Epigenetics: A Bidirectional Interplay that Drives Tumor Progression. Cells.

8:798, 2019

- Russi S, Verma HK, Laurino S, Mazzone P, Storto G, Nardelli A, Zoppoli P, Calice G, La Rocca F, Sgambato A, Lucci V, Falco G, Ruggieri V. Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells. Int J Mol Sci. 20:3736, 2019

- Russi S, Calice G, Ruggieri V, Laurino S, La Rocca F, Amendola E, Lapadula C, Compare D, Nardone G, Musto P, De Felice M, Falco G, Zoppoli P. Gastric Normal Adjacent Mucosa Versus Healthy and Cancer Tissues: Distinctive Transcriptomic Profiles and Biological Features. Cancers (Basel). 11:1248, 2019 - Crispo F, Notarangelo T, Pietrafesa M, Lettini G, Storto G, Sgambato A, Maddalena F, Landriscina M.

transcription co-factor, ZNF521, interacts with GLI1 and GLI2 and enhances the activity of the Sonic hedgehog pathway. Cell Death Dis. 10:715, 2019

- Guerriero I, De Angelis MT, D'Angelo F, Leveque R, Savignano E, Roberto L, Lucci V, Mazzone P, Laurino S, Storto G, Nardelli A, Sgambato A, Ceccarelli M, De Felice M, Amendola E, Falco G. Exploring the Molecular Crosstalk between Pancreatic Bud and Mesenchyme in Embryogenesis: Novel Signals Involved. Int J Mol Sci. 2019 Oct 3;20(19):4900.

- Caso A, Esposito G, Della Sala G, Pawlik JR, Teta R, Mangoni A, Costantino V. Fast Detection of Two Smenamide Family Members Using Molecular Networking. Mar Drugs. 17:618, 2019

- Imperatore C, Della Sala G, Casertano M, Luciano P, Aiello A, Laurenzana I, Piccoli C, Menna M. In Vitro Antiproliferative Evaluation of Synthetic Meroterpenes Inspired by Marine Natural Products. Mar Drugs.

17:684, 2019

- Tataranni T, Piccoli C. Dichloroacetate (DCA) and Cancer: An Overview towards Clinical Applications.

Oxid Med Cell Longev. 14, 2019

- Teta R, Sala GD, Esposito G, Via CW, Mazzoccoli C, Piccoli C, Bertin MJ, Costantino V, Mangoni A. A joint molecular networking study of a <i>Smenospongia</i> sponge and a cyanobacterial bloom revealed new antiproliferative chlorinated polyketides. Org Chem Front. 6:1762-1774, 2019

- Pietrafesa M, Maddalena F, Possidente L, Condelli V, Zoppoli P, Li Bergolis V, Rodriquenz MG, Aieta M, Vita G, Esposito F, Landriscina M. Gene Copy Number and Post-Transductional Mechanisms Regulate TRAP1 Expression in Human Colorectal Carcinomas. Int J Mol Sci. 21:145, 2019

- Lettini G, Lepore S, Crispo F, Sisinni L, Esposito F, Landriscina M. Heat shock proteins in cancer stem cell maintenance: A potential therapeutic target? Histol Histopathol. 35:25-37, 2019

Medicina nucleare:

- Gallicchio R, Mastrangelo PA, Nardelli A, Mainenti PP, Colasurdo AP, Landriscina M, Guglielmi G, Storto G. Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why. Tumori. 105:367-377, 2019

- Mainenti PP, Stanzione A, Guarino S, Romeo V, Ugga L, Romano F, Storto G, Maurea S, Brunetti A.

Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging. World J Gastroenterol. 25:5233-5256, 2019

Oncologia:

- Roviello G, Petrioli R, Rosellini P, Multari AG, Conca R, Paganini G, Chiriacò G, Aieta M. The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer. Invest New Drugs. 37:524-530, 2019

- Roviello G, Sohbani N, Petrioli R, Rodriquenz MG. Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy? Invest New Drugs.

37:1274-1288, 2019

- André F, Ciruelos E, Rubovszky G, Campone M, Loibl S, Rugo HS, Iwata H, Conte P, Mayer IA, Kaufman B, Yamashita T, Lu YS, Inoue K, Takahashi M, Pápai Z, Longin AS, Mills D, Wilke C, Hirawat S, Juric D, (Aieta M collaborator in appendice); SOLAR-1 Study Group. Alpelisib

for <i>PIK3CA</i>-Mutated, Hormone Receptor-Positive Advanced Breast Cancer. N Engl J Med.

2;380:1929-1940., 2019 (Pubblicazione non sottomessa alla valutazione del Ministero della Salute) - Tartarone A, Roviello G, Lerose R, Roudi R, Aieta M, Zoppoli P. Anti-PD-1 versus anti-PD-L1 therapy in patients with pretreated advanced non-small-cell lung cancer: a meta-analysis. Future Oncol. 15:2423-2433, 2019

- Roviello G, Corona SP, Conca R, Petrioli R, Rosellini P, Bonetta A, Aieta M. Is there still a place for vinorelbine in advanced metastatic castration resistant prostate cancer? Medicine (Baltimore). 98, 2019 - Roviello G, Corona SP, Multari AG, Petrioli R, Rosellini P, Aieta M. Poor outcome for patients with gastric cancer and lung metastases treated with ramucirumab and paclitaxel. Anticancer Drugs. 3, 2019 - Facchini G, Rossetti S, Berretta M, Cavaliere C, Scagliarini S, Vitale MG, Ciccarese C, Di Lorenzo G, Palesandro E, Conteduca V, Basso U, Naglieri E, Farnesi A, Aieta M, Borsellino N, La Torre L, Iovane G, Bonomi L, Gasparro D, Ricevuto E, De Tursi M, De Vivo R, Lo Re G, Grillone F, Marchetti P, De Vita F, Scavelli C, Sini C, Pisconti S, Crispo A, Gebbia V, Maestri A, Galli L, De

Giorgi U, Iacovelli R, Buonerba C, Cartenì G, D'Aniello C. Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results. J Transl Med. 17:296, 2019

- Arora SP, Liposits G, Caird S, Dunne RF, Moffat GT, Okonji D, Rodriquenz MG, Dua D, Dotan E.

Hepatocellular carcinoma in older adults: A comprehensive review by Young International Society of Geriatric Oncology. J Geriatr Oncol. 11:557-565, 2020

- Dieci MV, Bisagni G, Brandes AA, Frassoldati A, Cavanna L, Giotta F, Aieta M, Gebbia V, Musolino A, Garrone O, Donadio M, Rimanti A, Beano A, Zamagni C, Soto Parra H, Piacentini F, Danese S, Ferro A, Cagossi K, Sarti S, Gambaro AR, Romito S, Bazan V, Amaducci L, Moretti G, Foschini MP, Balduzzi S, Vicini R, D'Amico R, Griguolo G, Guarneri V, Conte PF. Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial. BMC Med. 17:207, 2019

- Canale ML, Camerini A, Huqi A, Lilli A, Bisceglia I, Parrini I, Lestuzzi C, Del Meglio J, Donati S, Venturini E, Sgambato A, Tarantini L, Amoroso D, Casolo G. Cardiovascular Risk Factors and Timing of Anthracyclines and Trastuzumab Cardiac Toxicity. Anticancer Res. 39:5741-5745, 2919

- Dubianski R, De Glas NA, Lewis AR, Rodriquenz MG, Okonji D, Gomes F, Battisti NML. Perspectives on geriatric oncology research presented at the 2019 ESMO Congress. J Geriatr Oncol. 11:543-548 2020

Radioterapia:

- Caravatta L, Cellini F, Simoni N, Rosa C, Niespolo RM, Lupattelli M, Picardi V, Macchia G, Sainato A, Mantello G, Dionisi F, Rosetto ME, Fusco V, Navarria F, De Paoli A, Guido A, Vecchi C, Basilico R, Cianci

- Cornacchia S, Errico R, La Tegola L, Maldera A, Simeone G, Fusco V, Niccoli- Asabella A, Rubini G, Guglielmi G. The new lens dose limit: implication for occupational radiation protection. Radiol Med.

124:728-735, 2019

- Cornacchia S, Errico R, Balzano RF, Fusco V, Maldera A, Pierpaoli E, Ferrari C, Rubini G, Guglielmi G.

Medical radiological procedures: which information would be chosen for the report? Radiol Med.

124:783-793, 2019

- Pedretti S, Masini L, Turco E, Triggiani L, Krengli M, Meduri B, Pirtoli L, Borghetti P, Pegurri L, Riva N, Gatta R, Fusco V, Scoccianti S, Bruni A, Ricardi U, Santoni R, Magrini SM, Buglione M. Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial. J Neurooncol. 143:447-455, 2019

- Cellini F, Manfrida S, Deodato F, Cilla S, Maranzano E, Pergolizzi S, Arcidiacono F, Di Franco R, Pastore F, Muto M, Borzillo V, Donati CM, Siepe G, Parisi S, Salatino A, D'Agostino A, Montesi G, Santacaterina A, Fusco V, Santarelli M, Gambacorta MA, Corvò R, Morganti AG, Masiello V, Muto P, Valentini V. Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial. Trials. 8;20:609, 2019

- Lancellotta V, De Sanctis V, Cornacchione P, Barbera F, Fusco V, Vidali C, Scalise S, Panza G, Tenore A, Colloca GF, Corvò R, Gambacorta MA, Magrini SM, Tagliaferri L. HAPPY - Humanity Assurance Protocol in interventional radiotheraPY (brachytherapy) - an AIRO Interventional Radiotherapy Study Group project. J Contemp Brachytherapy. 11:510-515, 2019

Linea di ricerca 2

FARMACI INNOVATIVI, TECNOLOGIE DIAGNOSTICHE AVANZATE E NUOVI BIOMARCATORI PER LA DEFINIZIONE DI 'TAILORED THERAPIES' NELLE EMOPATIE NEOPLASTICHE

Ematologia:

- Saltarella I, Morabito F, Giuliani N, Terragna C, Omedè P, Palumbo A, Bringhen S, De Paoli L, Martino E, Larocca A, Offidani M, Patriarca F, Nozzoli C, Guglielmelli T, Benevolo G, Callea V, Baldini L, Grasso M, Leonardi G, Rizzo M, Falcone AP, Gottardi D, Montefusco V, Musto P, Petrucci MT, Dammacco F, Boccadoro M, Vacca A, Ria R. Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial.

J Hematol Oncol. 12:4, 2019

- Girmenia C, Cavo M, Offidani M, Scaglione F, Corso A, Di Raimondo F, Musto P, Petrucci MT, Barosi G.

Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations. Blood Rev. 34:84-94, 2019

- Bringhen S, Mina R, Petrucci MT, Gaidano G, Ballanti S, Musto P, Offidani M, Spada S, Benevolo G, Ponticelli E, Galieni P, Cavo M, Di Toritto TC, Di Raimondo F, Montefusco V, Palumbo A, Boccadoro M, Larocca A. Once-weekly <i>versus</i> twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies. Haematologica. ;104:1640-1647, 2019 - D'Arena G, Galdo G, Musto P. Thalidomide-induced psoriasis in a patient with multiple myeloma.

Postgrad Med J. 95:171, 2019

- Fava C, Rege-Cambrin G, Dogliotti I, Cerrano M, Berchialla P, Dragani M, Rosti G, Castagnetti F, Gugliotta G, Martino B, Gambacorti-Passerini C, Abruzzese E, Elena C, Pregno P, Gozzini A, Capodanno I, Bergamaschi M, Crugnola M, Bocchia M, Galimberti S, Rapezzi D, Iurlo A, Cattaneo D, Latagliata R, Breccia M, Cedrone M, Santoro M, Annunziata M, Levato L, Stagno F, Cavazzini F, Sgherza N, Giai V, Luciano L, Russo S, Musto P, Caocci G, Sorà F, Iuliano F, Lunghi F, Specchia G, Pane F, Ferrero D, Baccarani M, Saglio G. Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice. Haematologica. 104:1589-1596, 2019

- Musto P, Statuto T, Valvano L, Grieco V, Nozza F, Vona G, Bochicchio GB, La Rocca F, D'Auria F. An update on biology, diagnosis and treatment of primary plasma cell leukemia. Expert Rev Hematol.

12:245-253, 2019

- D'Arena G, Galdo G, Lalinga V, Miraglia A, Pietrantuono G, Musto P, Vita G. Leg Type Primary Cutaneous Diffuse Large B-Cell Lymphoma. Indian J Hematol Blood Transfus. 35:378-379, 2019

- D'Arena G, Valvano L, Vitale C, Coscia M, Statuto T, Bellesi S, Lamorte D, Musto P, Laurenti L, D'Auria F. CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results. Leuk Res. 83:106169, 2019 - Montefusco V, Gay F, Spada S, De Paoli L, Di Raimondo F, Ribolla R, Musolino C, Patriarca F, Musto P,

- Autore F, Strati P, Innocenti I, Corrente F, Trentin L, Cortelezzi A, Visco C, Coscia M, Cuneo A, Gozzetti A, Mauro FR, Frustaci AM, Gentile M, Morabito F, Molica S, Falcucci P, D'Arena G, Murru R, Vincelli D, Efremov DG, Ferretti A, Rigolin GM, Vitale C, Tisi MC, Reda G, Visentin A, Sica S, Foà R, Ferrajoli A, Laurenti L. Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12. Cancers (Basel). 11:896, 2019

- Larocca A, Mina R, Offidani M, Liberati AM, Ledda A, Patriarca F, Evangelista A, Spada S, Benevolo G, OddoloD, Innao V, Cangiolosi C, Bernardini A, Musto P, Amico V, Fraticelli V, Paris L, Giuliani N, Falcone AP, Zambello R, De Paoli L, Romano A, Palumbo A, Montefusco V, Hájek R, Boccadoro M, Bringhen S.

First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide- dexamethasone followed by lenalidomide for transplant-ineligible multiple

myeloma patients: a pooled analysis of two randomized trials. Haematologica. 105:1074-1080, 2020 - Mele G, Pastore D, Di Renzo N, Fragasso A, Guarini A, Mazza P, Musto P, Pavone V, Tarantini G, Curci P, Falcone AP, Mele A, Miccolis MR, Palazzo G, Palumbo G, Quinto AM, Reddiconto G, Rizzi R, Cascavilla N, Specchia G, Capalbo SF. Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the 'Rete Ematologica Pugliese E Basilicata'. Leuk Lymphoma. 60:3565-3568, 2019

- Innocenti I, Morelli F, Autore F, Piciocchi A, Frustaci A, Mauro FR, Schiattone L, Trentin L, Del Poeta G, Reda G, Rigolin GM, Ibatici A, Ciolli S, Coscia M, Sportoletti P, Murru R, Levato L, Gentile M, D'Arena G, Efremov DG, Tedeschi A, Scarfò L, Cuneo A, Foà R, Laurenti L. Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience. Br J Haematol.

187:e8-e11, 2019

- Giudice A, Barbieri A, Bimonte S, Cascella M, Cuomo A, Crispo A, D'Arena G, Galdiero M, Della Pepa ME, Botti G, Caraglia M, Capunzo M, Arra C, Montella M. Dissecting the prevention of estrogen-dependent breast carcinogenesis through Nrf2-estrogen-dependent and inestrogen-dependent mechanisms. Onco Targets Ther. 12:4937-4953 2019

- Crugnola M, Castagnetti F, Breccia M, Ferrero D, Trawinska MM, Abruzzese E, Annunziata M, Stagno F, Tiribelli M, Binotto G, Bonifacio M, Fava C, Iurlo A, Bucelli C, Mansueto G, Gozzini A, Falzetti F, Montefusco E, Crisà E, Gugliotta G, Russo S, Cedrone M, RussoRossi A, Pregno P, Isidori A, Mauro E, Atelda R, Giglio G, Celesti F, Sorà F, Storti S, D'Addosio A, Galimberti S, Orlandi E, Calistri E, Bocchia M, Cavazzini F, Rege Cambrin G, Orofino N, Luciano L, Sgherza N, Rosti G, Latagliata R, Capodanno I.

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline. Ann Hematol. 98:2329-2338, 2019

- Arruga F, Bracciamà V, Vitale N, Vaisitti T, Gizzi K, Yeomans A, Coscia M, D'Arena G, Gaidano G, Allan JN, Furman RR, Packham G, Forconi F, Deaglio S. Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications. Leukemia.

34:462-477,

- Cohen JA, Rossi FM, Zucchetto A, Bomben R, Terzi-di-Bergamo L, Rabe KG, Degan M, Steffan A, Polesel J, Santinelli E, Innocenti I, Cutrona G, D' Arena G, Pozzato G, Zaja F, Chiarenza A, Rossi D, Di Raimondo F, Laurenti L, Gentile M, Morabito F, Neri A, Ferrarini M, Fegan CD, Pepper CJ, Del Poeta G, Parikh SA, Kay NE, Gattei V. A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia. Haematologica. Haematol.2019.228171, 2019

- Balleari E, Filiberti RA, Salvetti C, Allione B, Angelucci E, Bruzzone M, Calzamiglia T, Cavaliere M, Cavalleri M, Cilloni D, Clavio M, Crisà E, Da Col A, Danise P, Pilo F, Ferrero D, Finelli C, Gioia D, Lemoli RM,

Masiera E, Messa E, Miglino M, Musto P, Natalie Oliva E, Poloni A, Salvi F, Sanna A, Scudeletti M, Tassara R, Santini V. Effects of different doses of erythropoietin in patients

with myelodysplastic syndromes: A propensity score-matched analysis. Cancer Med. 8:7567-7576, 2019 - D'Arena G, Pietrantuono G, Mansueto G, Villani O, Zandolino A, Cammarota A. Parietal skull extramedullary relapse in multiple myeloma. Postgrad Med J. 96:360, 2020

Laboratori di ricerca:

- D'Auria F, Valvano L, Rago L, Statuto T, Calice G, D'Arena G, Fusco V, Musto P. Monoclonal B-cell lymphocytosis and prostate cancer: incidence and effects of radiotherapy. J Investig Med. 67:779-782, 2019

- Cannizzo E, Raia M, De Propris MS, Triolo A, Scarpati B, Marfia A, Stacchini A, Buccisano F, Lanza F, Regazzoli A, Michelutti A, Cesaro S, Conte CA, Vanelli L, Tedone E, Omedè P, Ciriello MM, Caporale R, Catinella V, Pantano G, De Rosa C, Lo Pardo C, Poletti G, Ulbar F, Pavanelli MC, Del Pup L, Ottaviano V, Santonocito AM, Bartocci C, Boscaro E, Arras M, Amodeo R, Mestice A, Oliva B, Ferrari L, Statuto T, D'Auria F, Pianezze G, Tanca D, Visconte F, Rubba F, Musto P, Geuna M, Gatti A, Brando B, Del Vecchio L. Features, reason for testing, and changes with time of 583 paroxysmal nocturnal hemoglobinuria clones from 529 patients: a multicenter Italian study. 98:1083-1093, 2019

- Nozza F, Vona G, Trino S, D'Auria F, La Rocca F, Grieco V, Possidente L, De Luca L, Musto P. A case of acute promyelocytic leukemia variant with derivative chromosome 3 der(3)t(3;8) associated with 8q partial gain. Mol Cytogenet. 12:32, 2019

- De Luca L, Laurenzana I, Trino S, Lamorte D, Caivano A, Musto P. An update on extracellular vesicles in multiple myeloma: a focus on their role in cell-to- cell cross-talk and as potential liquid biopsy biomarkers. Expert Rev Mol Diagn. 19:249-258, 2019

- Trino S, Zoppoli P, Carella AM, Laurenzana I, Weisz A, Memoli D, Calice G, La Rocca F, Simeon V, Savino L, Del Vecchio L, Musto P, Caivano A, De Luca L. DNA methylation dynamic of bone marrow hematopoietic stem cells after allogeneic transplantation. Stem Cell Res Ther. 10:138, 2019

- Russi S, Vincenti A, Vinella A, Mariggiò MA, Pavone F, Dammacco F, Lauletta G. CD5/CD20 expression on circulating B cells in HCV-related chronic hepatitis and mixed cryoglobulinemia. Eur J Intern Med.

66:48-56, 2019

- Tataranni T, Mazzoccoli C, Agriesti F, De Luca L, Laurenzana I, Simeon V, Ruggieri V, Pacelli C, Della Sala G, Musto P, Capitanio N, Piccoli C. Deferasirox drives ROS-mediated differentiation and induces interferon- stimulated gene expression in human healthy haematopoietic cells and in leukemia cells.

Stem Cell Res Ther. 10: 171, 2019.